Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-16-747227
Filing Date
2016-10-26
Accepted
2016-10-26 07:02:03
Documents
13
Period of Report
2016-10-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d276254d6k.htm 6-K 24671
2 GRAPHIC g27625401.jpg GRAPHIC 42129
3 GRAPHIC g27625402.jpg GRAPHIC 276156
4 GRAPHIC g27625403.jpg GRAPHIC 191217
5 GRAPHIC g27625404.jpg GRAPHIC 123966
6 GRAPHIC g27625405.jpg GRAPHIC 110753
7 GRAPHIC g27625406.jpg GRAPHIC 117283
8 GRAPHIC g27625407.jpg GRAPHIC 143128
9 GRAPHIC g27625408.jpg GRAPHIC 128189
10 GRAPHIC g27625409.jpg GRAPHIC 149658
11 GRAPHIC g27625410.jpg GRAPHIC 20343
12 GRAPHIC g276254txpg3a.jpg GRAPHIC 27166
13 GRAPHIC g276254txpg3b.jpg GRAPHIC 11659
  Complete submission text file 0001193125-16-747227.txt   1850460
Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
NOVOGEN LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 161951504
SIC: 2834 Pharmaceutical Preparations